English
Back
Download
Log in to access Online Inquiry
Back to the Top

$BioNTech (BNTX.US)$ The first colorectal cancer patient has...

$BioNTech (BNTX.US)$
The first colorectal cancer patient has been treated with BioNTech's (NASDAQ:BNTX) individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in a Phase 2 clinical trial.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
5
Translate
Report
37K Views
Comment
Sign in to post a comment
Apes4Ever
9
Followers
19
Following
133
Visitors
Follow
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.